The arrival of Retatrutide ZPHC, at a concentration of 120mg, is creating considerable excitement within the medical community. This novel dual GIP and GLP-1 receptor medication appears to deliver notable improvements in fat shedding compared to previous therapies. Preliminary patient data have d